Reliever Inhaled Glucocorticoid Treatment

Reliever Inhaled Glucocorticoid TreatmentBlack and Latinx patients are disproportionately impacted by asthma. In fact, asthma mortality rates are twice as high in Black patients compared to White patients. Are there different treatment options to help improve mortality in these populations? Join host Geoff Wall with guest Dr. Matt Trump as they discuss the PREPARE trial.The GameChangerEmerging data suggests that using a bronchodilator with an inhaled corticosteroid (ICS) may improve asthma exacerbation symptoms in diverse patient populations. This is contrary to current standards of care that encourage the use of a short-acting bronchodilator alone.  Show Segments00:00 – Introduction02:05 – Asthma in Diverse Populations04:25 – Inhaled Corticosteroids in Asthma Management 06:50 – PREPARE Trial                                                                                   18:33 – The GameChanger28:11 – Closing Remarks HostGeoff Wall, PharmD., BCPS, FCCP, CGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint HealthGuestDr. Matt Trump, DO, FACP, FCCPPulmonary & Critical Care SpecialistThe Iowa ClinicDr. Trump is a consultant for Fishter and Paykel Healthcare and an investigator for Astra Zeneca. All relevant financial relationships have been mitigated.References and ResourcesReliever-Triggered Inhaled Glucocorticoid in Black and Latinx Adults with Asthma Redeem CPE or CMERedeem CPE (Pharmacists)Redeem CME (Prescribers)Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)Pharmacists: Get a membershipPrescribers: Get a membershipCE InformationLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1.     Describe the disparity of outcomes in asthma between different demographics2.     Discuss the role of reliever inhaled glucocorticoids for persons with asthma 0.05 CEU/0.5 HrUAN: 0107-0000-22-176-H01-PInitial release date: 04/25/2022         Expiration date: 04/25/2023Additional CPE and CME details can be found here. Follow CEimpact on Social Media:LinkedInInstagram